Clinical Trial Update: A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for guselkumab in moderately to severely active Crohn's disease (Phase 2/3) with status ACTIVE_NOT_RECRUITING and results posted in May 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn's Disease | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-07